Endoscopic ultrasound-guided intratumoural therapy for pancreatic cancer

Canadian Journal of Gastroenterology

Volumn 22, Issue 4, 2008, Pages 405-410

  Yan, Brian M ^a   Van Dam, Jacques ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brachytherapy; Cytoimplant; Dendritic cells; Endoscopic ultrasound; Fiducials; Fine needle injection; ONYX 015; Pancreatic cancer; Photodynamic therapy; Radiofrequency ablation; TNFerade

Indexed keywords

ADENOVIRUS VECTOR; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; APOPTOSIS INDUCING FACTOR; ERLOTINIB; FLUOROURACIL; GADOLINIUM; GEMCITABINE; IODINE 125; NANOTUBE; ONCOLYTIC VIRUS; ONYX 015; PACLITAXEL; PALLADIUM 103; PHOTOFRIN; PHOTOSENSITIZING AGENT; POLYMER; TNFERADE; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT THERAPY; ASPIRATION BIOPSY; BILE DUCT OBSTRUCTION; BRACHYTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CELL TRANSPLANTATION; CLINICAL PRACTICE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTRAST ENHANCEMENT; DENDRITIC CELL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; DISEASE MODEL; DRUG DELIVERY SYSTEM; DUODENUM PERFORATION; ENDOSCOPIC ECHOGRAPHY; HUMAN; HYDROGEL; HYPOTENSION; INTERMETHOD COMPARISON; LYMPHOCYTE TRANSFER; MEDICAL RESEARCH; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLYTIC VIROTHERAPY; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS RESECTION; PANCREATITIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; SWINE; UNSPECIFIED SIDE EFFECT;

EID: 44649198658     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/104398     Document Type: Review

References (46)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer Clin 2001;51:15,36.
2. Reis L, Eisner M, Kosary C, et al. SEER Cancer Statistics Review, 1975-2002. Bethesda: National Cancer Institute, 2005.
3. Kuvshinoff BW, Bryer MP. Treatment of resectable and locally advanced pancreatic cancer. Cancer Control 2000;7:428-36.
4. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group. Cancer 1987;59:2006-10.
5. Klinkenbijl JH, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999;230:776-82; discussion 782-4.
6. Hoffman JP, Lipsitz S, Pisansky T, Weese JL, Solin L, Benson AB III. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. J Clin Oncol 1998;16:317-23.
7. Burris HA III, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol 1997;15:2403-13.
8. Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine versus observation in patients undergoing curativeintent resection of pancreatic cancer: A randomized controlled trial. JAMA 2007;297:267-77.
9. Yip D, Karapetis C, Strickland A, Steer CB, Goldstein D. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. Cochrane Database Syst Rev 2006;3:CD002093.
10. Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007;25:1960-6.
11. Pino SM, Xiong HQ, McConkey D, Abbruzzese JL. Novel therapies for pancreatic adenocarcinoma. Curr Gastroenterol Rep 2004;6:119-25.
12. Rosemurgy AS, Serafini FM. New directions in systemic therapy of pancreatic cancer. Cancer Control 2000;7:437-51.
13. DeWitt J, Devereaux B, Chriswell M, et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 2004;141:753-63.
14. Kochman ML. EUS in pancreatic cancer. Gastrointest Endosc 2002;56(4 Suppl):S6-S12.
15. Muller MF, Meyenberger C, Bertschinger P, Schaer R, Marincek B. Pancreatic tumors: Evaluation with endoscopic US, CT, and MR imaging. Radiology 1994;190:745-51.
16. Palazzo L, Roseau G, Gayet B, et al. Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinorna. Results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy 1993;25:143-50.
17. Brugge WR. The role of endoscopic ultrasound in the diagnosis and staging of pancreatic malignancy. US Gastroenterolgy Review 2006:37-41.
18. Gress FG, Hawes RH, Savides TJ, et al. Role of EUS in the preoperative staging of pancreatic cancer: A large single-center experience. Gastrointestinal endoscopy 1999;50:786-91.
19. Shami VM, Parmar KS, Waxman I. Clinical impact of endoscopic ultrasound and endoscopic ultrasound-guided fine-needle aspiration in the management of rectal carcinoma. Dis Colon Rectum 2004;47:59-65.
20. Fazel A, Draganov P. Interventional endoscopic ultrasound in pancreatic disease. Curr Gastroenterol Rep 2004;6:104-10.
21. Klapman JB, Chang KJ. Endoscopic ultrasound-guided fine-needle injection. Gastrointest Endosc Clin N Am 2005;15:169-177, x.
22. Chang KJ, Nguyen PT, Thompson JA, et al. Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma. Cancer 2000;88:1325-35.
23. Senzer N, Mani S, Rosemurgy A, et al. TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: A phase I study in patients with solid tumors. J Clin Oncol 2004;22:592-601.
24. Farrell JJ, Senzer N, Hecht JR, et al. Long-term data for endoscopic ultrasound (EUS) and percutaneous (PTA) guided intratumoral TNFerade gene delivery combined with chemoradiation in the treatment of locally advanced pancreatic cancer (LAPC). Gastrointestinal Endoscopy 2006;63:AB93. (Abst)
25. Posner M, Chang K, Rosemurgy A, et al. Multi-center, phase 2/3, randomized, controlled clinical trial using TNFerade gene delivery combined with chemoradiation in patients with locally advanced pancreatic cancer (LAPC). American Society of Clinical Oncology Annual Meeting. Chicago, June 2007. (Abst)
26. Ries SJ. Elucidation of the molecular mechanism underlying tumor-selective replication of the oncolytic adenovirus mutant ONYX-015. Future Oncol 2005;1:763-66.
27. Hecht JR, Bedford R, Abbruzzese JL, et al. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin Cancer Res 2003;9:555-61.
28. Goldberg SN, Mallery S, Gazelle GS, Brugge WR. EUS-guided radiofrequency ablation in the pancreas: Results in a porcine model. Gastrointest Endosc 1999;50:392,401.
29. Bown SG, Rogowska AZ, Whitelaw DE, et al. Photodynamic therapy for cancer of the pancreas. Gut 2002;50:549-57.
30. Chan HH, Nishioka NS, Mino M, et al. EUS-guided photodynamic therapy of the pancreas: A pilot study. Gastrointest Endosc 2004;59:95-9.
31. Sun S, Xu H, Xin J, et al. Endoscopic ultrasound-guided interstitial brachytherapy of unresectable pancreatic cancer: Results of a pilot trial. Endoscopy 2006;38:399-403.
32. Jin Z, Li Z, Du Y, Jiang Y, Chen J. Endoscopic ultrasonography-guided interstitial implantation of iodine 125 seeds combined with chemotherapy in the treatment of unresectable abdominal carcinoma: A prospective study. Gastrointest Endosc 2007;65:AB105. (Abst)
33. Meenan J, Mesenas S, Douglas N, et al. EUS-delivered therapy for pancreatic cancer: Initial experience with targeted injection of 32P biosilicon. Gastrointest Endosc 2007;65:AB208. (Abst)
34. Bhattacharyya M, Lemoine NR. Gene therapy developments for pancreatic cancer. Best Pract Res Clin Gastroenterol 2006;20:285-98.
35. Matthes K, Mino-Kenudson M, Sahani DV, et al. EUS-guided injection of paclitaxel (OncoGel) provides therapeutic drug concentrations in the porcine pancreas (with video). Gastrointest Endosc 2007;65:448-53.
36. Sun S, Wang S, Ge N, et al. Endoscopic ultrasound-guided interstitial chemotherapy in the pancreas: Results in a canine model. Endoscopy 2007;39:530-34.
37. Vignesh S, Wilson L, Hartman K, et al. EUS FNI of gadolinium-loaded ultra-short carbon nanotubes (GDNT) into porcine pancreas boosts the MR T1 signal 25-fold. Gastrointest Endosc 2007;65:AB195. (Abst)
38. Koong AC, Le QT, Ho A, et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2004;58:1017-21.
39. Koong AC, Christofferson E, Le QT, et al. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2005;63:320-3.
40. Pishvaian AC, Collins B, Gagnon G, Ahlawat S, Haddad NG. EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies. Gastrointest Endosc 2006;64:412-7.
41. Ellsmere JC, Mahadevan A, Kelleher T, Chuttani RAM, Pleskow DK. EUS-guided radiotherapy fiducials for upper gastrointestinal malignancies. Gastrointest Endosc 2007;65:AB208. (Abst)
42. Banchereau J, Paczesny S, Blanco P et al. Dendritic cells: controllers of the immune system and a new promise for immunotherapy. Ann N Y Acad Sci 2003;987:180-7.
43. Vicari AP, Caux C, Trinchied G. Tumour escape from immune surveillance through dendritic cell inactivation. Semin Cancer Biol 2002;12:33-42.
44. Dallal RM, Christakos P, Lee K, Egawa S, Son YI, Lotze MT. Paucity of dendritic cells in pancreatic cancer. Surgery 2002;131:135-8.
45. Schnurr M, Galambos P, Scholz C, et al. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: An in vitro model for the assessment of tumor vaccines. Cancer Res 2001;61:6445-50.
46. Nonogaki K, Hirooka Y, Itoh A, et al. Combined treatment with immunotherapy and chemotherapy using endoscopic ultrasonography: A phase 1 trial as first line treatment in patients with locally advanced pancreatic carcinoma. Gastrointest Endosc 2007;65:AB207. (Abst)